Reveals important new results from clinical trials conducted in Scandinavia Scotland Australia Canada and the United States. This timely reference reviews the vast body of clinical trial evidence supporting the once controversial view that high levels of serum cholesterol are a major risk factor in coronary heart disease (CHD). The studies presented in Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence promote cholesterol reduction as a highly successful means of preventing heart disease in various populations. Investigates past current and upcoming controlled clinical trials of cholesterol-reduction therapies comparing effects of statins and bile acid sequestrants to triglyceride-lowering drugs and antioxidants. Written by more than 25 distinguished international researchers Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence highlights historical studies of dietary trials designed to reduce CHD covers tests of HMG Co A reductase inhibitors for patients with and without CHD illuminates CHD risk factors such as diabetes hypertension obesity and smoking explores blood levels of homocysteine and lipoprotein(a) and other recently identified CHD risk factors reviews metabolism of lipoproteins expressed in high (HDL) and low (LDL) density lipoprotein cholesterol and more! Containing over 700 instructive tables drawings photographs and bibliographic citations Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence is a must-read resource for cardiologists pharmacologists and upper-level undergraduate graduate and medical school students in these disciplines. |Cholesterol-Lowering Therapy Evaluation of Clinical Trial Evidence | Life Science
